Patients are frequently told they have raised blood sugars or a borderline HbA1c, but many leave their GP appointments with little understanding of what this actually means, what their true risk of developing type 2 diabetes is, or what they can do about it
The platform acknowledges that oral GLP-1 therapy isn't suitable for everyone precisely because the administration requirements are non-negotiable for effectiveness
In answering the daily laxative question, quite honestly, it depends on the type of laxative youre using and why
The published Phase 3 mean weight reduction for retatrutide (28.3%) is nearly double the figure for semaglutide in STEP-1 (14.9%) over comparable trial durations
Kraemer WJ, Spiering BA, Volek JS, Ratamess NA, Sharman MJ, Rubin MR, French DN, Silvestre R, Hatfield DL, Van Heest JL, Vingren JL, Judelson DA, Deschenes MR, Maresh CM